Guhan Traditional Chinese Medicine Co., Ltd. announced that it will receive CNY 22 million in a round of funding on December 30, 2022. The transaction will include participation from returning investor Tus-Pharmaceutical Group Co., Ltd. The company issued common shares in the transaction. The transaction has been approved in the ninth session of the Board of Directors and the ninth session of the Supervisory Committee.

The registered capital of the company is CNY 128 million.